# A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer

> **NCT07414992** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 44 (estimated)

## Conditions studied

- Bladder Urothelial Carcinoma

## Interventions

- **RADIATION:** Stereotactic body radiotherapy
- **DRUG:** Cemiplimab
- **DRUG:** Cemiplimab and Fianlimab
- **PROCEDURE:** Radical cystectomy

## Key facts

- **NCT ID:** NCT07414992
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2028-03
- **Final completion:** 2028-03
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07414992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07414992, "A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07414992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*